Government Privatising Bosnalijek As Serbia Pulls Out Of Galenika Sale

The Balkan pharmaceutical markets are among the fastest growing in Emerging Europe. Generic-oriented at present, these markets have the potential to evolve rapidly over the next five years. The privatisation of domestic champions in these markets holds an interesting opportunity for investment, but respective governments appear largely reluctant to relinquish their stakes.

To read the full article, please choose one of the following options: